114 related articles for article (PubMed ID: 6829497)
1. A randomized study of continuous infusion vindesine versus vinblastine in adults with refractory metastatic sarcomas.
Yap BS; Benjamin RS; Plager C; Burgess MA; Papadoupoulos N; Bodey GP
Am J Clin Oncol; 1983 Apr; 6(2):235-8. PubMed ID: 6829497
[TBL] [Abstract][Full Text] [Related]
2. Vindesine in the treatment of refractory breast cancer: improvement in therapeutic index with continuous 5-day infusion.
Yap HY; Blumenschein GR; Bodey GP; Hortobagyi GN; Buzdar AU; DiStefano A
Cancer Treat Rep; 1981; 65(9-10):775-9. PubMed ID: 7273012
[TBL] [Abstract][Full Text] [Related]
3. Phase II evaluation of vindesine sulfate in patients with advanced sarcomas.
Sordillo PP; Magill GB; Gralla RJ
Cancer Treat Rep; 1981; 65(5-6):515-6. PubMed ID: 7237472
[No Abstract] [Full Text] [Related]
4. A comparative randomized trial of vinca alkaloids in patients with metastatic breast carcinoma.
Yau JC; Yap YY; Buzdar AU; Hortobagyi GN; Bodey GP; Blumenschein GR
Cancer; 1985 Jan; 55(2):337-40. PubMed ID: 3880657
[TBL] [Abstract][Full Text] [Related]
5. Continuous vindesine infusion in advanced head and neck cancer.
Popkin JD; Bromer RH; Vaughan CW; Byrne RE; Licciardello JT; Hoffer SM; Welch JM; Fofonoff SA; Strong MS; Hong WK
Am J Clin Oncol; 1983 Jun; 6(3):301-4. PubMed ID: 6846248
[TBL] [Abstract][Full Text] [Related]
6. Vindesine in the treatment of metastatic breast cancer.
Hansen PV; Brincker H
Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1221-5. PubMed ID: 6541581
[TBL] [Abstract][Full Text] [Related]
7. Continuous infusion vindesine in solid tumors.
Bodey GP; Yap HY; Yap BS; Valdivieso M
Cancer Treat Rev; 1980 Sep; 7 Suppl 1():39-45. PubMed ID: 7438120
[No Abstract] [Full Text] [Related]
8. Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas.
Borden EC; Amato DA; Edmonson JH; Ritch PS; Shiraki M
Cancer; 1990 Sep; 66(5):862-7. PubMed ID: 2201431
[TBL] [Abstract][Full Text] [Related]
9. [Vindesine and adriamycin in the therapy of metastatic breast cancer].
Wander HE; Nagel GA
Onkologie; 1982 Aug; 5 Suppl():5-7. PubMed ID: 6752792
[TBL] [Abstract][Full Text] [Related]
10. [Primary chemotherapy in soft tissue sarcomas considered inoperable].
Rouëssé J; Le Chevalier T; Contesso G; Sarrazin D; Amiel JL; Sevin D; Carde P; Génin J
Sem Hop; 1983 May; 59(19):1441-4. PubMed ID: 6310758
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of vindesine infusion in visceral metastatic malignant melanoma.
Wagstaff J; Anderson HA; Shiu W; Thatcher N
Cancer Treat Rep; 1983 Sep; 67(9):839-40. PubMed ID: 6883362
[No Abstract] [Full Text] [Related]
12. Multicenter phase II trial with 5-day continuous infusion of vindesine in metastatic malignant melanoma.
Mayol XF; Beltran J; Rubio-Bazan R; Rifa J; Costa RR; Lopez JJ
Cancer Treat Rep; 1984 Sep; 68(9):1199-200. PubMed ID: 6444204
[No Abstract] [Full Text] [Related]
13. Chemotherapy of patients with advanced soft tissue sarcoma with use of DVA (vindesine sulfate), adriamycin and cyclophosphamide (DAC).
Brenner J; Magill GB; Wissel P; Sordillo PP
Cancer; 1983 Oct; 52(7):1142-5. PubMed ID: 6349786
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of vindesine bolus and infusion.
Jackson DV; Sethi VS; Long TR; Muss HB; Spurr CL
Cancer Chemother Pharmacol; 1984; 13(2):114-9. PubMed ID: 6467494
[TBL] [Abstract][Full Text] [Related]
15. [Continuous 5-day vindesine in the treatment of leukemias and lymphomas (author's transl)].
Maraninchi D; Gastaut JA; Tubiana N; Carcassonne Y
Bull Cancer; 1981; 68(4):338-42. PubMed ID: 6947833
[TBL] [Abstract][Full Text] [Related]
16. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
Fuks JZ; Aisner J; Carney DN; Van Echo DA; Ostrow SS; Ihde DC; Wiernik PH
Am J Clin Oncol; 1982 Feb; 5(1):49-52. PubMed ID: 6282108
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of Baker's antifol in metastatic sarcoma.
Thigpen JT; O'Bryan RM; Benjamin RS; Coltman CA
Cancer Treat Rep; 1977 Nov; 61(8):1485-7. PubMed ID: 922752
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of vindesine in patients with metastatic breast cancer.
Cobleigh MA; Williams SD; Einhorn LH
Cancer Treat Rep; 1981; 65(7-8):659-63. PubMed ID: 7248983
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.
Blaney SM; Needle MN; Gillespie A; Sato JK; Reaman GH; Berg SL; Adamson PC; Krailo MD; Bleyer WA; Poplack DG; Balis FM
Clin Cancer Res; 1998 Feb; 4(2):357-60. PubMed ID: 9516923
[TBL] [Abstract][Full Text] [Related]
20. Toxicity and pharmacology of bolus vindesine injection and prolonged vindesine infusion.
Hande K; Gay J; Gober J; Greco FA
Cancer Treat Rev; 1980 Sep; 7 Suppl 1():25-30. PubMed ID: 7438118
[No Abstract] [Full Text] [Related]
[Next] [New Search]
